This World Obesity Day, discover how modern medicine is redefining our understanding of hunger.
Image: Pexels.
Hunger, for most of us, is a feeling we’ve been taught to tame, to control, to overpower. It’s long been framed as a matter of willpower, a battle between mind and mouth.
However, science paints a more complex picture.
Hunger isn’t just a fleeting desire, it is a deeply biological signal, orchestrated by hormones, digestion, activity levels and even our environment.
As South Africa marks World Obesity Day on March 4, with the global theme “8 Billion Reasons to Act on Obesity”, it’s the perfect moment to reflect on how modern medicine is reshaping the way we understand appetite.
The rise of GLP-1 receptor agonist weight loss medications like Ozempic, Wegovy and Mounjaro has cracked open the door to a new narrative.
These drugs, initially developed for Type 2 diabetes, have shed light on the biological intricacies of appetite control, challenging decades of stigma and misconceptions. So, here are five lessons these medications have taught us about hunger and why it’s so much more than a test of self-control.
1. Appetite begins in the gut, not the brain
We often think of hunger as a mental game, but it’s the gut that calls the shots. Hormones like GLP-1 (glucagon-like peptide-1) are produced in the gut after we eat, signalling satiety and slowing digestion.
Think of GLP-1 as your body's internal “fullness whisperer,” working behind the scenes to regulate how quickly nutrients enter the bloodstream and how much energy your body absorbs.
But hunger isn’t a one-note symphony. Other hormones like ghrelin, released by the stomach, work to stimulate appetite, while GLP-1 rises post-meal to quiet those signals.
This intricate dance of hormones underscores the biological complexity of hunger. It’s a system shaped by digestion, microbes and nutrient absorption, all sending whispers to the brain.
2. GLP-1 medications extend natural hunger signals
GLP-1 receptor agonists don’t just block hunger, they amplify and extend the natural processes already at work. Under normal conditions, GLP-1 levels rise for about two hours after eating, signalling your body to slow down digestion and suppress appetite. These medications mimic GLP-1 but keep those signals active for much longer, creating a lasting sensation of fullness.
The relationship between hunger and physical activity is complex.
Image: Pexels.
This isn’t about tricking your body but working with its natural rhythms. By slowing gastric emptying and maintaining a “fed” state, these drugs help reduce calorie intake over time while supporting sustainable weight loss.
It’s a physiological shift, not a quick fix and one that underscores just how dynamic appetite regulation really is.
3. Hunger isn’t always logical or linear
Hunger doesn’t operate in a straight line.
Research in exercise and nutrition reveals that physical activity often scrambles the hunger signals we expect. Intense workouts, particularly high-intensity interval training (HIIT), can suppress appetite temporarily, thanks to shifts in gut hormones like GLP-1. But don’t be fooled, cravings often come roaring back later, as the body works to restore balance.
This ebb and flow remind us that hunger isn’t simply about burning calories versus consuming them. It’s a complex interplay of biology, activity and environment. And while GLP-1 medications can help smooth out some of these fluctuations, they don’t remove the body’s need for essential nutrients and hydration.
4. Weight loss is gradual and highly individual
Let’s be clear: GLP-1 medications aren’t magic bullets. For most people, they lead to gradual weight loss, typically around 5 to 8% of body weight over several months. But outcomes vary widely, influenced by genetics, lifestyle and adherence to medical advice.
Weightloss significantly varies due to factors like genetics and lifestyle choices.
Image: Pexels.
What these medications do offer is a new lens through which to view obesity.
For decades, weight was framed as a matter of personal responsibility, a narrative steeped in blame and stigma.
GLP-1 therapies shift the focus to biology, highlighting the gut-brain axis and the role of hormones in regulating appetite.
This paradigm shift is changing public conversations about obesity, offering a more compassionate understanding of weight management.
5. Nutritional balance still matters
Reducing appetite doesn’t mean reducing the body’s need for nutrients or fluids. When food intake decreases, it becomes even more critical to focus on nutrition and hydration.
The human body loses 2 to 3 litres of fluid daily through sweat, urine and even breathing, fluid that must be replaced to support circulation, organ function and temperature regulation.
With appetite reduction comes the need for heightened focus on nutrition.
Image: Pexels.
This is where collaboration with dieticians and nutritionists becomes essential. Maintaining a balanced intake of vitamins, minerals and hydration ensures that weight loss doesn’t come at the expense of health.
As much as GLP-1 medications can assist in appetite control, they’re only one piece of the puzzle.